Logistics Present Yet Another Challenge for Clinical Genomics

When evaluating the potential of clinical genomics, a lot of attention is rightly focused on the challenges of interpretation, and the need for more phenotypes to power statistically-driven interpretation of clinically relevant variants. But another challenge exists...

Oncologists Struggle to Utilize Precision Medicine

  The challenges faced by oncologists in using biomarker-based tests were underlined in a recent article by Dr. Marcus Neubauer in OncLive. In recent posts in this blog I have focused on the challenges of interpreting genomic data, but Dr. Neubauer emphasizes two...

FDA and CMS Have Formed a Joint Task Force for LDT Co-Regulation

FDA and CMS have just announced that the agencies are forming a joint task force to explore “areas where collaboration may realize greater oversight efficiency and produce the greatest benefit to patients, providers, and laboratories.” This is a laudable...